» Articles » PMID: 23051179

Viral Infections and Molecular Mimicry in Type 1 Diabetes

Overview
Journal APMIS
Date 2012 Oct 12
PMID 23051179
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Type 1 diabetes (T1D) is a disease characterized by inflammation of pancreatic islets associated with autoimmunity against insulin-producing beta cells, leading to their progressive destruction. The condition constitutes a significant and worldwide problem to human health, particularly because of its rapid, but thus far unexplained, increase in incidence. Environmental factors such as viral infections are thought to account for this trend. While there is no lack of reports associating viral infections toT1D, it has proven difficult to establish which immunological processes link viral infections to disease onset or progression. One of the commonly discussed pathways is molecular mimicry, a mechanism that encompasses cross-reactive immunity against epitopes shared between viruses and beta cells. In this review, we will take a closer look at mechanistic evidence for a potential role of viruses in T1D, with a special focus on molecular mimicry.

Citing Articles

Type 1 diabetes: immune pathology and novel therapeutic approaches.

Ling E, Lemos J, Hirani K, von Herrath M Diabetol Int. 2024; 15(4):761-776.

PMID: 39469552 PMC: 11512973. DOI: 10.1007/s13340-024-00748-z.


Decoding the relationship between cow's milk proteins and development of type 1 diabetes mellitus.

Andrade L, Oliveira G, de Oliveira L, Bittencourt A, Baumgarth Y, Oliveira L Arch Endocrinol Metab. 2024; 68:e230248.

PMID: 39420935 PMC: 11460975. DOI: 10.20945/2359-4292-2023-0248.


The Role of the Nrf2 Pathway in Airway Tissue Damage Due to Viral Respiratory Infections.

Kombe Kombe A, Fotoohabadi L, Nanduri R, Gerasimova Y, Daskou M, Gain C Int J Mol Sci. 2024; 25(13).

PMID: 39000157 PMC: 11241721. DOI: 10.3390/ijms25137042.


The relationship between SARS-CoV-2 infection and type 1 diabetes mellitus.

Debuysschere C, Nekoua M, Alidjinou E, Hober D Nat Rev Endocrinol. 2024; 20(10):588-599.

PMID: 38890459 DOI: 10.1038/s41574-024-01004-9.


The Impact of Microbiota-Immunity-Hormone Interactions on Autoimmune Diseases and Infection.

Martinelli S, Nannini G, Cianchi F, Coratti F, Amedei A Biomedicines. 2024; 12(3).

PMID: 38540229 PMC: 10967803. DOI: 10.3390/biomedicines12030616.


References
1.
Filippi C, Estes E, Oldham J, von Herrath M . Immunoregulatory mechanisms triggered by viral infections protect from type 1 diabetes in mice. J Clin Invest. 2009; 119(6):1515-23. PMC: 2689128. DOI: 10.1172/JCI38503. View

2.
Tanaka S, Nishida Y, Aida K, Maruyama T, Shimada A, Suzuki M . Enterovirus infection, CXC chemokine ligand 10 (CXCL10), and CXCR3 circuit: a mechanism of accelerated beta-cell failure in fulminant type 1 diabetes. Diabetes. 2009; 58(10):2285-91. PMC: 2750208. DOI: 10.2337/db09-0091. View

3.
Redondo M, Yu L, Hawa M, Mackenzie T, Pyke D, Eisenbarth G . Heterogeneity of type I diabetes: analysis of monozygotic twins in Great Britain and the United States. Diabetologia. 2001; 44(3):354-62. DOI: 10.1007/s001250051626. View

4.
Richardson S, Willcox A, Bone A, Foulis A, Morgan N . The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes. Diabetologia. 2009; 52(6):1143-51. DOI: 10.1007/s00125-009-1276-0. View

5.
Fujinami R, Oldstone M . Molecular mimicry as a mechanism for virus-induced autoimmunity. Immunol Res. 1989; 8(1):3-15. DOI: 10.1007/BF02918552. View